Literature DB >> 117484

The involvement of serotonergic neurons in the central nervous system as the possible mechanism for slow head-shaking behavior induced by methamphetamine in rats.

T Honma, H Fukushima.   

Abstract

Following the IV administration of d-methamphetamine (MA), rats showed slow head shaking (SHS) and stereotyped gnawing (SG) behaviors in a dose-dependent manner. Methysergide, cyrpoheptadine, and p-chlorophenylalanine given intracerebroventricularly (ICV) or systemically significantly blocked SHS behavior induced by 10 mg/kg MA. Combined administration of L-5-hydroxytryptophan and peripheral decarboxylase inhibitor (Ro 4-4602) enhanced SHS behavior. Tyrosine hydroxylase inhibitor (H44/68) blocked SG behaviors, but dopamine-beta-hydroxylase inhibitors (FLA 63 and U-14, 624) and combined administration of L-3,4-dihydroxyphenylalanine and Ro-4-4602 enhanced it. These drugs did not affect SHS behavior. Phentolamine, phenoxybenzamine, clonidine, isoproterenol, and propranolol given ICV or systemically showed no effect on either SHS or SG behaviors. These results suggest that SHS behavior is produced by the activation of seronergic neurons in the central nervous system and are consistent with the view that SG behaviors are mediated through the release of dopamine. Some neuroleptics inhibited SHS as well as SG behaviors, but the older of inhibitory activity of neuroleptics onSHS behavior was quite different from their effects on SG behaviors induced by MA or apomorphine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 117484     DOI: 10.1007/bf00433042

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Spontaneous and amphetamine induced head-shaking in infant rats.

Authors:  B Holmgren; R Urbá-Holmgren; M Valdés
Journal:  Pharmacol Biochem Behav       Date:  1976-07       Impact factor: 3.533

2.  Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.

Authors:  T Honma; H Fukushima
Journal:  Neuropharmacology       Date:  1976-10       Impact factor: 5.250

3.  ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.

Authors:  C B SMITH
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

4.  [Mechanism of methamphetamine toxicity in grouped mice and the effects of centrally acting drugs on its toxicity (author's transl)].

Authors:  T Honma
Journal:  Nihon Yakurigaku Zasshi       Date:  1978-01

Review 5.  Drugs acting through dopamine release.

Authors:  A Carlsson
Journal:  Pharmacol Ther B       Date:  1975

6.  [Effects of minor tranquilizers and neuroleptics on open-field behavior in rats (author's transl)].

Authors:  T Honma; S Kitagawa
Journal:  Nihon Yakurigaku Zasshi       Date:  1977-04

7.  Effects of 5-hydroxytryptophan on arterial blood pressure, body temperature and tissue monoamines in the rat.

Authors:  M Henning; A Rubenson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

8.  Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation.

Authors:  A Pletscher; G Bartholini
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

9.  Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.

Authors:  T H Svensson
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.